Cite
HARVARD Citation
Ottaiano, A. et al. (2021). Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol. Therapeutic advances in medical oncology. p. . [Online].